The rousing biographical drama centred on one of the most renowned figures in science will be leaving Netflix on August 16.

SNUG01 showed favorable safety and signs of early clinical efficacy in a recently completed investigator-initiated trial in China, the firm said.

In that moment, things clicked. A year ago, my father died after an absolutely brutal battle with amyotrophic lateral ...

By decoding neural signals linked to a person’s inner monologue, researchers enabled communication for individuals with ...

In a recent study, scientists successfully decoded not only the words people tried to say but the words they merely imagined saying.

A new discovery about mutations in a gene that causes ALS may allow researchers to design targeted therapies, a study found.

The Company plans to hold an end-of-Phase 2 Type B meeting with the FDA in the third quarter of 2025. This meeting will review results from the Phase 2 VISIONARY-MS trial and discuss the planned Phase ...

When approached for a quote about Jeffrey D Rothstein, Professor of Neurology and Neuroscience and Director of the Brain Science Institute at Johns Hopkins School of Medicine (Baltimore MD, USA), his ...

Therapeutic advances have altered the neurodegenerative trajectory and improved clinical outcomes for individuals with spinal muscular atrophy. Current therapies increase concentrations of survival ...

Stone will be joining Dane — whom she has been friends with "for a long time" — on the long-awaited third season of the HBO ...

Answer ALS, in collaboration with ALS Therapy Development Institute (ALS TDI) and Augie's Quest, today announced plans to ...